NYSE$CLW
Clearwater Paper Corporation · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
Reported a net loss driven by planned major maintenance and acquisition costs, while sales increased due to the Augusta facility acquisition and strong tissue demand.
Clearwater Paper reported a net loss of $26 million for Q2 2024, compared to a net income of $30 million in Q2 2023. Net sales increased by 12% to $586 million, primarily driven by incremental sales volume from the Augusta acquisition. Adjusted EBITDA was $35 million, down from $71 million in the same period last year due to the impact of planned major maintenance.
- Completed the acquisition of the Augusta paperboard manufacturing facility.
- Net sales increased by 12% year-over-year, primarily driven by the Augusta facility.
- Net loss was $26 million, compared to net income of $30 million in the second quarter of last year.
- Adjusted EBITDA decreased to $35 million, impacted by planned major maintenance at the Lewiston facility.
Headline financials
Revenue & EPS history
Clearwater Paper · Revenue · Quarterly
$586M
Forward guidance
Clearwater Paper expects gradual demand recovery for paperboard through the balance of 2024 and into 2025. The sale of the tissue business is expected to close in the fourth quarter of 2024, with proceeds used to de-lever the balance sheet and grow the paperboard product portfolio.
Tailwinds
- Confident in the long-term fundamentals of the paperboard market.
- Expects gradual demand recovery for paperboard for the balance of 2024 and into 2025.
- Plans to use proceeds from the sale of the tissue business to de-lever the balance sheet.
- Will continue executing strategy to grow and diversify paperboard product portfolio.
- Sale of tissue business expected to close in Q4 2024.
Headwinds
- Closing conditions and regulatory approval are required for the sale of the tissue business.
- Potential delays in the sale of the tissue business.
- Possible unexpected costs, charges, or expenses from the pending tissue business sale transaction.
- Risk of stockholder litigation in connection with the tissue business sale transaction or the acquisition of the Augusta, Georgia paperboard manufacturing facility.
- Inability to realize the expected benefits of the Augusta, Georgia paperboard manufacturing facility acquisition because of integration difficulties or other challenges.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2024
-2.7%
Avg return
Earnings day
-4.4%
Avg return
5 days after
-4.0%
Avg return
30 days after
39%
26 / 66 earnings
Positive
+24.1%
Q1 2022
Best reaction
-33.5%
Q1 2018
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -13.5% | -14.3% | +9.8% | |
| Q4 2025 | -8.6% | -15.1% | -26.6% | |
| Q3 2025 | -8.5% | -6.2% | -5.8% | |
| Q2 2025 | -18.4% | -24.9% | -26.7% | |
| Q1 2025 | +7.4% | +4.0% | +15.1% | |
| Q4 2024 | -8.4% | -3.9% | -17.6% | |
| Q3 2024 | +8.3% | +4.8% | +5.0% | |
| Q2 2024 | -23.3% | -34.5% | -39.1% | |
| Q1 2024 | +12.0% | +12.4% | +30.3% | |
| Q4 2023 | +3.4% | +7.5% | +21.7% | |
| Q3 2023 | -2.1% | +3.1% | +1.2% | |
| Q2 2023 | +14.8% | +10.9% | +18.8% | |
| Q1 2023 | -15.9% | -12.2% | -18.7% | |
| Q4 2022 | -0.2% | -1.0% | -10.8% | |
| Q3 2022 | -15.1% | -10.4% | -10.4% | |
| Q2 2022 | +15.3% | +20.1% | +18.4% | |
| Q1 2022 | +24.1% | +20.8% | +28.6% | |
| Q4 2021 | -12.7% | -7.4% | -6.0% | |
| Q3 2021 | +0.4% | -6.5% | +0.5% | |
| Q2 2021 | +2.1% | +8.4% | +18.5% | |
| Q1 2021 | -10.0% | -14.0% | -16.4% | |
| Q4 2020 | -18.7% | -15.1% | -11.4% | |
| Q3 2020 | -12.2% | -13.2% | -8.0% | |
| Q2 2020 | +2.5% | -4.7% | -14.1% | |
| Q1 2020 | +21.2% | +21.5% | +36.5% | |
| Q4 2019 | +10.2% | +11.2% | -18.5% | |
| Q3 2019 | +2.2% | -0.4% | +6.1% | |
| Q2 2019 | -13.9% | -0.3% | -18.5% | |
| Q1 2019 | -10.7% | -3.7% | -20.1% | |
| Q4 2018 | -16.0% | -17.0% | -25.4% | |
| Q3 2018 | -6.6% | -6.3% | -0.9% | |
| Q2 2018 | +11.9% | +14.8% | +28.5% | |
| Q1 2018 | -33.5% | -40.3% | -35.8% | |
| Q4 2017 | -25.1% | -23.0% | -13.8% | |
| Q3 2017 | +3.2% | +4.5% | +4.0% | |
| Q2 2017 | -9.2% | -9.0% | -6.6% | |
| Q1 2017 | -13.4% | -12.6% | -18.8% | |
| Q4 2016 | -6.7% | -3.9% | -17.3% | |
| Q3 2016 | -14.7% | -15.3% | -3.7% | |
| Q2 2016 | -7.1% | -5.4% | -11.0% | |
| Q1 2016 | +10.1% | — | — | |
| Q4 2015 | -5.9% | — | — | |
| Q3 2015 | +1.2% | — | — | |
| Q2 2015 | +10.2% | — | — | |
| Q1 2015 | +1.8% | — | — | |
| Q4 2014 | -17.4% | — | — | |
| Q3 2014 | +0.4% | — | — | |
| Q2 2014 | +12.0% | — | — | |
| Q1 2014 | -1.4% | — | — | |
| Q4 2013 | +9.6% | — | — | |
| Q3 2013 | +8.3% | — | — | |
| Q2 2013 | -0.7% | — | — | |
| Q1 2013 | -8.6% | — | — | |
| Q4 2012 | +4.3% | — | — | |
| Q3 2012 | -6.6% | — | — | |
| Q2 2012 | +4.9% | — | — | |
| Q1 2011 | -0.9% | — | — | |
| Q1 2012 | +7.2% | — | — | |
| Q4 2009 | -0.4% | — | — | |
| Q1 2010 | -0.4% | — | — | |
| Q4 2011 | -0.4% | — | — | |
| Q3 2011 | -1.8% | — | — | |
| Q3 2010 | -1.8% | — | — | |
| Q2 2010 | -5.2% | — | — | |
| Q4 2010 | -5.2% | — | — | |
| Q2 2011 | -5.2% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro